Get the Stockscreener App
364.98
0.01%
-0.03
After Hours:
364.98
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $364.98, with a volume of 472.11K.
It is down -0.01% in the last 24 hours and up +6.52% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$365.01
Open:
$364.74
24h Volume:
472.11K
Relative Volume:
0.75
Market Cap:
$25.69B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
48.79
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
-1.47%
1M Performance:
+6.52%
6M Performance:
+43.24%
1Y Performance:
+33.61%
1-Day Range:
$363.26
$368.85
1-Week Range:
$363.12
$378.47
52-Week Range:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
364.98 | 26.07B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
391.95 | 138.47B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list - cnbc.com
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical Services stock reports 13.80 percent revenue growth - AD HOC NEWS
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research
West Pharmaceutical Services stock attracts analyst coverage - AD HOC NEWS
West Pharmaceutical stock enters earnings watch with USD 382.00 target - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
What Comes Next for West Pharmaceutical Services (NYSE:WST)? - Kalkine Media
Top West Pharmaceutical Services (WST) Competitors 2026 - MarketBeat
West Pharmaceutical Services stock gains after target rises - AD HOC NEWS
West Pharmaceutical stock rises 1.30 percent ahead of the open - AD HOC NEWS
West Pharmaceutical stock rises 2.71 percent after analyst upgrade - AD HOC NEWS
West Pharmaceutical stock gains 2.57 percent before the bell - AD HOC NEWS
West Pharmaceutical stock gains as Morgan Stanley turns bullish - AD HOC NEWS
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says - marketscreener.com
West Pharmaceutical Services stock holds near its yearly range - AD HOC NEWS
Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 - Yahoo Finance
West Pharmaceutical stock holds near 52-week high as valuation debate intensifies - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with 11.89% Potential Upside - DirectorsTalk Interviews
West Pharmaceutical stock heads into the open after a 1.3% drop - AD HOC NEWS
West Pharmaceutical Services stock holds near fair value as valuation debate intensifies - AD HOC NEWS
What Is Drawing Attention To West Pharmaceutical Services (WST)? - Yahoo Finance
West Pharmaceutical Services stock holds a Moderate Buy rating - AD HOC NEWS
West Pharmaceutical stock holds Moderate Buy rating as Annex 1 work shapes outlook - ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Yahoo Finance
West Pharma to cut 98 jobs as SmartDose production winds down in Arizona - Plastics News
West Pharmaceutical stock slips after recent Fed-driven drop but Q2 2026 results stay strong - AD HOC NEWS
West Pharmaceutical stock heads into the open after a sharp drop - AD HOC NEWS
West Pharmaceutical stock gains after raised 2026 guidance and strong Q2 figures - AD HOC NEWS
West Pharmaceutical stock heads into the open after a 2.76% gain - AD HOC NEWS
Is West Pharmaceutical Services Stock Outperforming the Nasdaq? - Yahoo Finance
West Pharmaceutical (NYSE: WST) HR leader exercises options, then sells 7,524 shares - Stock Titan
West Pharmaceutical Services Inc (WST): GF Score of 95 Signals S - GuruFocus
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $365 - Moomoo
West Pharmaceutical stock heads into the open after a 1.8% gain - AD HOC NEWS
Earnings Call Transcripts - Investing.com
West Pharmaceutical Services (WST) Stock Analysis: Robust Growth and a Promising 17% Upside - DirectorsTalk Interviews
West Pharmaceutical stock gains after insider sale and strong Q2 figures - ad-hoc-news.de
West Pharmaceutical Services senior VP favorite sells $2.77m in stock - Investing.com
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical CEO Michel Lagarde Granted Stock Options and RSUs in September 2026 - Kalkine Media
WEST PHARMACEUTICAL SERVICES, INC. : UBS RAISES TARGET PRICE TO $415 FROM $340 - webull.com
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com Nigeria
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - Investing.com
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
West Pharmaceutical Services Inc Stock (WST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 11 '26 |
Option Exercise |
89.64 |
2,500 |
224,100 |
24,318 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 14 '26 |
Option Exercise |
89.64 |
2,500 |
224,100 |
24,318 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 15 '26 |
Sale |
365.00 |
2,524 |
921,260 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 14 '26 |
Sale |
355.00 |
2,500 |
887,500 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 11 '26 |
Sale |
345.00 |
2,500 |
862,500 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 08 '26 |
Option Exercise |
85.37 |
8,135 |
694,453 |
19,663 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 08 '26 |
Sale |
340.81 |
8,135 |
2,772,489 |
16,845 |
0.28%
1.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):